SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-007600
Filing Date
2020-04-13
Accepted
2020-04-13 16:17:38
Documents
2
Period of Report
2020-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20200411_8k.htm 8-K 26184
2 EXHIBIT 4.1 FORM OF 2020 OPTION AGREEMENT ex_181168.htm EX-4.1 34802
  Complete submission text file 0001437749-20-007600.txt   62266
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 20788962
SIC: 2834 Pharmaceutical Preparations